Avivomed Inc., a Minneapolis-based medical device company, announced a $32 million Series A round of financing on Thursday.
The company said in a statement a "world-class syndicate of medical device investors" were involved in the round that will allow the company to develop neuromodulation technology that will treat patients suffering from chronic diseases.
Aviviomed also announced it has hired Steve Masson as president and CEO. Masson has 40 years of experience in the medical device business including at Cordis, Ventritex, InnerPulse and NeuroTronik.
"We look forward to partnering with our seasoned investor group, feel fortunate to have them on our team, and to benefit from their broad base of expertise," Masson said in a statement.
